Skip to main content
S&P 5007,706.03-0.75%DOW51,511.59-0.68%NASDAQ26,936.04-1.13%BTC$84,421.00-2.09%ETH$2,684.89-2.47%GOLD$4,325.30+0.16%OIL$92.04-0.13%
Smart Investors Daily
Chemed Corporation logo

NYSE · CHE

Chemed Corporation

Healthcare · Medical - Care Facilities

$496.62

Up+$1.47 (+0.30%)

Updated Sep 24, 2026, 12:08 AM

SID Score

5.6/10

Composite research score

Smart Money

58/100

Neutral

Market cap
6.27B
P/E ratio
22.37
Dividend yield
0.44%
52-week range
$365.21 – $557.00
Volume
132.26K
Avg. volume
182.63K

Price performance

CHE price history

1M range · 19 trading sessions · Daily adjusted prices

CHE closed at $496.62 after 19 trading sessions, down 9.47% for the selected period.

Last close
$496.62
Period change
-9.47%
Period low
$496.62
Period high
$548.56
Daily close
View OHLC price history
CHE OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 22, 2026$500.55$505.79$495.37$496.62132.26K
Sep 21, 2026$507.79$509.59$496.97$499.62159.28K
Sep 18, 2026$504.50$512.25$498.23$504.06417.57K
Sep 17, 2026$509.06$516.88$500.52$505.97144.67K
Sep 16, 2026$506.75$513.5425$500.935$509.91141.08K
Sep 15, 2026$511.55$511.55$499.175$506.47176.42K
Sep 14, 2026$515.81$521.50$510.40$514.29129.67K
Sep 11, 2026$517.04$526.47$510.0826$515.9781.83K
Sep 10, 2026$520.22$530.18$509.025$514.4090.92K
Sep 9, 2026$517.77$519.095$511.09$518.57106.32K
Sep 8, 2026$515.00$525.255$512.86$519.01132.3K
Sep 4, 2026$519.62$525.63$519.23$519.8484.28K
Sep 3, 2026$528.28$533.685$516.95$524.45136.02K
Sep 2, 2026$515.58$527.515$509.01$523.99129.97K
Sep 1, 2026$521.72$534.1689$514.675$515.17142.24K
Aug 31, 2026$522.33$523.70$517.29$518.7196.65K
Aug 28, 2026$521.61$526.7799$517.38$523.38150.58K
Aug 27, 2026$543.70$545.795$501.84$520.27363.76K
Aug 26, 2026$544.56$551.36$541.655$548.56128.65K

Latest CHE news

The latest Smart Investors Daily articles mentioning CHE.

Stock researchCompany · Overview

CHE research

Overview

Company profile and research snapshot.

Company profile

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$550.00
Implied upside
—
Analysts
—
CHE recent ratings
DateFirmRatingTarget
Jul 31, 2026OppenheimerOutperform—
Jul 30, 2026RBC CapitalSector Perform—
Jul 9, 2026B of A SecuritiesNeutral—
Apr 27, 2026RBC CapitalSector Perform—
Feb 27, 2026OppenheimerOutperform—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 16, 2026

Roto-Rooter Buys Largest Franchisee Territory

CINCINNATI, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced it has acquired the largest independent Roto-Rooter franchise, serving a population of approximately 11 million people, for $60.6 million. Prior to the acquisition, this franchise had annual revenue of between $50.0 and $55.0 million. The territories acquired include Northern San Diego, Palm Springs, Ventura, Bakersfield, Lancaster, Fresno,

Yahoo · Sep 8, 2026

Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference

CINCINNATI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2026 Healthcare Services and Technology Conference on Tuesday, September 15, 2026, at approximately 10:55 a.m. (CT) at the 1 Hotel in Nashville. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By